Copper and iron in nutritional immunity

铜和铁在营养免疫中的作用

基本信息

  • 批准号:
    10308477
  • 负责人:
  • 金额:
    $ 41.88万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-01-17 至 2023-11-30
  • 项目状态:
    已结题

项目摘要

The objective of this proposal is to elucidate the mechanisms by which the copper­containing ferroxidase, ceruloplasmin, regulates nutritional immunity against bacterial infection. There is an urgent need to understand mechanisms of nutrient homeostasis in order to develop more effective treatments and therapies. Nutritional immunity describes mechanisms that alter host metal ion homeostasis during microbial infection. An important aspect of nutritional immunity is iron withholding from bacterial pathogens via hypoferremia (low plasma iron levels). Hypoferremia is regulated by peptide hormone, hepcidin, which restricts iron export into the plasma by inducing the degradation of the iron exporter, ferroportin in hepatocytes, enterocytes and macrophages. Another mechanism of nutritional immunity involves hypercupremia (high plasma copper levels). This process occurs via increased hepatic secretion of ceruloplasmin, a copper carrying ferroxidase that contains the majority of copper in the plasma. Copper is thought to facilitate killing of bacterial pathogens via macrophages of the innate immune system, however, the role of ceruloplasmin in this process is unknown. Despite its identification as an acute phase protein more than 60 years ago, the requirement for ceruloplasmin during infection remains unknown. As a ferroxidase, ceruloplasmin facilitates iron export via ferroportin, however, this function is unnecessary during infection due to ferroportin degradation. Thus, it is likely that ceruloplasmin has alternative functions during infection. Preliminary results demonstrate that ceruloplasmin knockout mice are highly susceptible to systemic infection by the bacterial pathogens Salmonella typhimurium and Staphylococcus aureus. In addition, ceruloplasmin knockout mice were found to exhibit reduced serum levels of proinflammatory cytokines when challenged with bacterial ligands to Toll­like receptors (TLRs), highlighting a possible role for ceruloplasmin in TLR signaling. In this proposal, biochemical and genetic approaches will be used to understand the contribution of ceruloplasmin to nutritional immunity. AIM1 tests the role of iron and copper on hypersensitivity of ceruloplasmin-­null mice to infection. AIM 2 seeks to understand the role of ceruloplasmin in TLR signaling within macrophages. AIM 3 investigates whether macrophage or hepatocyte expression of ceruloplasmin is required for host immunity.
该提案的目的是阐明含铜亚铁氧化酶、铜蓝蛋白调节针对细菌感染的营养免疫的机制。迫切需要了解营养稳态的机制,以便开发更有效的治疗方法。营养免疫描述了微生物感染期间改变宿主金属离子稳态的机制。营养免疫的一个重要方面是通过低铁血症(低血浆铁水平)抑制细菌病原体的铁。低铁血症由肽激素铁调素调节,铁调素通过诱导肝细胞、肠上皮细胞和巨噬细胞中的铁输出蛋白、铁转运蛋白的降解来限制铁输出到血浆中。营养免疫的另一种机制涉及高铜血症(高血浆铜水平)。这一过程是通过肝脏分泌铜蓝蛋白增加而发生的,铜蓝蛋白是一种携带铜的亚铁氧化酶,血浆中含有大部分铜。铜被认为有助于通过先天免疫系统的巨噬细胞杀死细菌病原体,然而,铜蓝蛋白在此过程中的作用尚不清楚。尽管 60 多年前就已将其鉴定为急性期蛋白,但感染过程中对铜蓝蛋白的需求仍然未知。作为一种铁氧化酶,铜蓝蛋白通过铁转运蛋白促进铁输出,然而,由于铁转运蛋白降解,该功能在感染期间是不必要的。因此,铜蓝蛋白可能在感染期间具有替代功能。初步结果表明,铜蓝蛋白敲除小鼠对细菌病原体鼠伤寒沙门氏菌和金黄色葡萄球菌的全身感染高度敏感。此外,发现铜蓝蛋白敲除小鼠在受到 Toll 样受体 (TLR) 细菌配体攻击时,血清中促炎细胞因子水平降低,这凸显了铜蓝蛋白在 TLR 信号传导中的可能作用。在该提案中,将使用生化和遗传学方法来了解铜蓝蛋白对营养免疫的贡献。 AIM1 测试铁和铜对铜蓝蛋白缺失小鼠感染超敏反应的作用。 AIM 2 旨在了解铜蓝蛋白在巨噬细胞内 TLR 信号传导中的作用。 AIM 3 研究宿主免疫是否需要巨噬细胞或肝细胞表达铜蓝蛋白。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Ceruloplasmin as a source of Cu for a fungal pathogen.
  • DOI:
    10.1016/j.jinorgbio.2021.111424
  • 发表时间:
    2021-06
  • 期刊:
  • 影响因子:
    3.9
  • 作者:
    Besold AN;Shanbhag V;Petris MJ;Culotta VC
  • 通讯作者:
    Culotta VC
Copper metabolism as a unique vulnerability in cancer.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHAEL J. PETRIS其他文献

MICHAEL J. PETRIS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHAEL J. PETRIS', 18)}}的其他基金

Targeting vulnerabilities in copper metabolism in the development of cancer therapies
针对癌症疗法开发中铜代谢的脆弱性
  • 批准号:
    10461152
  • 财政年份:
    2021
  • 资助金额:
    $ 41.88万
  • 项目类别:
Targeting vulnerabilities in copper metabolism in the development of cancer therapies
针对癌症疗法开发中铜代谢的脆弱性
  • 批准号:
    10683333
  • 财政年份:
    2021
  • 资助金额:
    $ 41.88万
  • 项目类别:
Targeting vulnerabilities in copper metabolism in the development of cancer therapies
针对癌症疗法开发中铜代谢的脆弱性
  • 批准号:
    10280230
  • 财政年份:
    2021
  • 资助金额:
    $ 41.88万
  • 项目类别:
Novel roles of copper in adaptive responses to hypoxia
铜在缺氧适应性反应中的新作用
  • 批准号:
    10614637
  • 财政年份:
    2021
  • 资助金额:
    $ 41.88万
  • 项目类别:
Novel roles of copper in adaptive responses to hypoxia
铜在缺氧适应性反应中的新作用
  • 批准号:
    10345243
  • 财政年份:
    2021
  • 资助金额:
    $ 41.88万
  • 项目类别:
Copper and iron in nutritional immunity
铜和铁在营养免疫中的作用
  • 批准号:
    10066346
  • 财政年份:
    2019
  • 资助金额:
    $ 41.88万
  • 项目类别:
2017 Cell Biology of Metals Gordon Research Conference and Gordon Research Seminar
2017金属细胞生物学戈登研究会议暨戈登研究研讨会
  • 批准号:
    9328227
  • 财政年份:
    2017
  • 资助金额:
    $ 41.88万
  • 项目类别:
Copper metabolism as a unique vulnerability in cancer
铜代谢是癌症的独特弱点
  • 批准号:
    9178063
  • 财政年份:
    2014
  • 资助金额:
    $ 41.88万
  • 项目类别:
Copper metabolism as a unique vulnerability in cancer
铜代谢是癌症的独特弱点
  • 批准号:
    8974819
  • 财政年份:
    2014
  • 资助金额:
    $ 41.88万
  • 项目类别:
Copper metabolism as a unique vulnerability in cancer
铜代谢是癌症的独特弱点
  • 批准号:
    8797173
  • 财政年份:
    2014
  • 资助金额:
    $ 41.88万
  • 项目类别:

相似国自然基金

基于构建骨骼类器官模型探究Fanconi anemia信号通路调控电刺激诱导神经化成骨过程的机制研究
  • 批准号:
    82302715
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
FANCM蛋白在传统Fanconi anemia通路以外对保护基因组稳定性的功能
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
范可尼贫血(Fanconi Anemia)基因FANCM在复制后修复中的作用及FA癌症抑制通路的机制研究
  • 批准号:
    31200592
  • 批准年份:
    2012
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Investigation of crosstalk between Fanconi Anemia pathway and ATM for novel therapeutic strategies of chemoresistant ALT-positive high-risk neuroblastoma
范可尼贫血通路与 ATM 之间的串扰研究,用于化疗耐药 ALT 阳性高危神经母细胞瘤的新治疗策略
  • 批准号:
    24K10442
  • 财政年份:
    2024
  • 资助金额:
    $ 41.88万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Immune escape mechanisms in BCOR/BCORL1 mutant hematopoietic stem cells from patients with aplastic anemia
再生障碍性贫血患者 BCOR/BCORL1 突变型造血干细胞的免疫逃逸机制
  • 批准号:
    23K15297
  • 财政年份:
    2023
  • 资助金额:
    $ 41.88万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Fanconi anemia経路に着目したiPS細胞における高レベル複製ストレスの原因解明
阐明 iPS 细胞中高水平复制应激的原因,重点关注范可尼贫血途径
  • 批准号:
    23K14452
  • 财政年份:
    2023
  • 资助金额:
    $ 41.88万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Analysis of the mechanism of hemolytic anemia in canine babesiosis and development of novel therapeutic measures
犬巴贝斯虫病溶血性贫血机制分析及新治疗措施开发
  • 批准号:
    23KJ0074
  • 财政年份:
    2023
  • 资助金额:
    $ 41.88万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Brain blood flow, oxygenation, and cognition in adult onset iron deficiency anemia
成人缺铁性贫血的脑血流量、氧合和认知
  • 批准号:
    10735765
  • 财政年份:
    2023
  • 资助金额:
    $ 41.88万
  • 项目类别:
Chromatin State Alterations in Fanconi Anemia Hematologic Disease and Bone Marrow Failure
范可尼贫血血液疾病和骨髓衰竭中的染色质状态改变
  • 批准号:
    10735366
  • 财政年份:
    2023
  • 资助金额:
    $ 41.88万
  • 项目类别:
Liver-Gut Axis in Neonatal Anemia and Its Role in RBC Transfusion Associated Gut Injury
新生儿贫血中的肝肠轴及其在红细胞输注相关肠道损伤中的作用
  • 批准号:
    10583807
  • 财政年份:
    2023
  • 资助金额:
    $ 41.88万
  • 项目类别:
Small Molecule Therapeutics for Sickle Cell Anemia
镰状细胞性贫血的小分子疗法
  • 批准号:
    10601679
  • 财政年份:
    2023
  • 资助金额:
    $ 41.88万
  • 项目类别:
Accuracy and Feasibility of Non-Invasive Anemia Screening Assistant (ASIST) Device in Resource-Limited Settings
资源有限环境中非侵入性贫血筛查辅助 (ASIST) 设备的准确性和可行性
  • 批准号:
    10575222
  • 财政年份:
    2023
  • 资助金额:
    $ 41.88万
  • 项目类别:
Mobile phone-based screening for anemia in young children in western Kenya
基于手机的肯尼亚西部幼儿贫血筛查
  • 批准号:
    10752968
  • 财政年份:
    2023
  • 资助金额:
    $ 41.88万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了